Skip to main content

Table 1 The ITaLi-Q questionnaire

From: Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation

DomainNo. of itemsRangeDescription
Side effects40–100A higher score indicates a higher frequency of HBIG-related side effects
Side effects impact30–100A higher score indicates a higher impact of HBIG-related side effects on daily activities
Negative feelings60–100A higher score is associated with more negative, therapy-associated feelings (e.g., anxiety and fatigue)
Positive feelings50–100A higher score is associated with more positive, therapy-associated feelings (e.g., the perceived importance of one’s own health status)
Flexibility80–100A higher score corresponds to a more disturbing impact of therapy on daily-life flexibility (e.g., planning work or leisure)
Support30–100The higher the score, the greater is the level of support received to adhere to therapy (e.g., being reminded or being accompanied to outpatient follow-up visits)
Need for support30–100The higher the score, the greater is the perceived need for support to adhere to therapy
Satisfaction50–100A higher score indicates a higher degree of satisfaction related to HBIG therapy (e.g., overall satisfaction, satisfaction with the route of administration, and flexibility)